Compare RNAZ & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNAZ | CNF |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9M | 31.9M |
| IPO Year | 2021 | 2018 |
| Metric | RNAZ | CNF |
|---|---|---|
| Price | $1.04 | $2.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 19.2K | 6.2K |
| Earning Date | 11-16-2026 | 08-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.28 | $1.37 |
| 52 Week High | $12.60 | $6.49 |
| Indicator | RNAZ | CNF |
|---|---|---|
| Relative Strength Index (RSI) | 25.80 | 69.37 |
| Support Level | N/A | $2.12 |
| Resistance Level | $1.93 | $2.46 |
| Average True Range (ATR) | 0.16 | 0.15 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 6.42 | 96.71 |
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, the group generates all of its revenues in the PRC.